Stocks and Investing
Stocks and Investing
Thu, August 25, 2016
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, August 24, 2016
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tim Chiang Maintained (TEVA) at Strong Buy and Held Target at $75 on, Aug 24th, 2016
Tim Chiang of BTIG, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Strong Buy and Held Target at $75 on, Aug 24th, 2016.
Tim has made no other calls on TEVA in the last 4 months.
There are 2 other peers that have a rating on TEVA. Out of the 2 peers that are also analyzing TEVA, 1 agrees with Tim's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Vamil Divan of "Credit Suisse" Initiated at Hold and Held Target at $60 on, Wednesday, May 4th, 2016
This is the rating of the analyst that currently disagrees with Tim
- David Risinger of "Morgan Stanley" Maintained at Buy with Decreased Target to $69 on, Tuesday, May 3rd, 2016